Preston Klassen's Net Worth
$1.64 Million
Who is Preston Klassen?
Preston Klassen has an estimated net worth of $1.64 Million. This is based on reported shares across multiple companies, which include Metacrine, Inc., Orexigen Therapeutics, Inc., ARENA PHARMACEUTICALS INC, Conatus Pharmaceuticals Inc, Regulus Therapeutics Inc., and JATT Acquisition Corp.
SEC CIK
Preston Klassen's CIK is 0001493056
Past Insider Trading and Trends
2011 was Preston Klassen's most active year for acquiring shares with 5 total transactions. Preston Klassen's most active month to acquire stocks was the month of December. 2011 was Preston Klassen's most active year for disposing of shares, totalling 7 transactions. Preston Klassen's most active month to dispose stocks was the month of June. 2019 saw Preston Klassen paying a total of $286,900.00 for 112,900 shares, this is the most they've acquired in one year. In 2019 Preston Klassen cashed out on 46,609 shares for a total of $908,328.24, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Metacrine, Inc. No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -37.83% | -842.21K |
$0.47 | -$395,839.17 | 1.38M |
Mar 23
| |||
Form 4
| -41.26% | -380.61K |
$0.41 | -$157,265.99 | 541.9K |
Jan 26
| |||
Form 4
| -4.63% | -44.75K |
$0.50 | -$22,472.08 | 922.51K |
Apr 19
| |||
Form 4
| +12.11% | 104.5K |
—
|
—
| 967.26K |
Apr 14
| |||
Form 4
| +4,098.95% | 842.21K |
—
|
—
| 862.76K |
Feb 27
| |||
Form 4
|
∞
| 20.55K |
$3.64 | $74,692.45 | 20.55K |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Orexigen Therapeutics, Inc. No price found
EVP, Global Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +146.00% | 6.03K |
$2.69 | $16,221.30 | 10.16K |
May 30 - Feb 2
| |||
Form 4
| +225.20% | 2.86K |
$5.07 | $14,506.14 | 4.13K |
May 30 - Feb 3
| |||
Form 4
|
∞
| 1.27K |
$5.34 | $6,781.80 | 1.27K |
Nov 29 - Feb 7
| |||
Form 4
|
—
|
0
|
$4.41 | -$391,759.50 |
0
|
Scheduled
|
Jul 25
| ||
Form 4
|
—
|
0
|
$4.43 | -$159,598.49 |
0
|
Scheduled
|
May 28
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 22 - Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ARENA PHARMACEUTICALS INC No price found
EVP and CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
∞
| 3.99K |
$47.32 | -$109,261.88 | 3.99K |
Oct 14
| |||
Form 4
|
—
|
0
|
$28.58 | -$512,166.36 |
0
|
Scheduled
|
Jan 4 - Jan 8
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Conatus Pharmaceuticals Inc (HSTO) Snapshot price: $0.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Regulus Therapeutics Inc. (RGLS) Snapshot price: $1.48
President & Head R & D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |